News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,037 Results
Type
Article (42337)
Company Profile (283)
Press Release (690401)
Multimedia
Podcasts (90)
Webinars (20)
Section
Business (205839)
Career Advice (2038)
Deals (35685)
Drug Delivery (128)
Drug Development (81636)
Employer Resources (173)
FDA (16505)
Job Trends (15017)
News (348055)
Policy (32844)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2642)
Accelerated approval (45)
Adcomms (26)
Allergies (169)
Alliances (50069)
ALS (205)
Alzheimer's disease (1774)
Antibody-drug conjugate (ADC) (432)
Approvals (16869)
Artificial intelligence (643)
Autoimmune disease (258)
Automation (53)
Bankruptcy (364)
Best Places to Work (11669)
BIOSECURE Act (21)
Biosimilars (217)
Biotechnology (189)
Bladder cancer (184)
Brain cancer (72)
Breast cancer (730)
Cancer (5693)
Cardiovascular disease (455)
Career advice (1729)
Career pathing (41)
CAR-T (319)
CDC (55)
Celiac Disease (3)
Cell therapy (852)
Cervical cancer (46)
Clinical research (70661)
Collaboration (2028)
Company closure (5)
Compensation (1334)
Complete response letters (77)
COVID-19 (2749)
CRISPR (106)
C-suite (1078)
Cystic fibrosis (150)
Data (7555)
Decentralized trials (3)
Denatured (27)
Depression (157)
Dermatology (76)
Diabetes (575)
Diagnostics (6978)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (313)
Drug pricing (199)
Drug shortages (31)
Duchenne muscular dystrophy (274)
Earnings (91600)
Editorial (65)
Employer branding (21)
Employer resources (152)
Events (119614)
Executive appointments (1066)
FDA (20127)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1682)
Gene editing (234)
Generative AI (55)
Gene therapy (689)
GLP-1 (1039)
Government (4736)
Grass and pollen (6)
Guidances (403)
Healthcare (19048)
HIV (78)
Huntington's disease (55)
IgA nephropathy (93)
Immunology and inflammation (282)
Immuno-oncology (87)
Indications (176)
Infectious disease (3083)
Inflammatory bowel disease (205)
Inflation Reduction Act (14)
Influenza (135)
Intellectual property (286)
Interviews (318)
IPO (16706)
IRA (50)
Job creations (3661)
Job search strategy (1438)
JPM (58)
Kidney cancer (18)
Labor market (96)
Layoffs (560)
Leadership (37)
Legal (7968)
Liver cancer (100)
Longevity (33)
Lung cancer (757)
Lymphoma (421)
Machine learning (59)
Management (59)
Manufacturing (995)
MASH (179)
Medical device (13963)
Medtech (14061)
Mergers & acquisitions (20198)
Metabolic disorders (1462)
mRNA (199)
Multiple sclerosis (183)
NASH (17)
Neurodegenerative disease (400)
Neuropsychiatric disorders (103)
Neuroscience (3248)
Neurotech (1)
NextGen: Class of 2026 (6559)
Non-profit (4548)
Now hiring (76)
Obesity (685)
Opinion (289)
Ovarian cancer (209)
Pain (246)
Pancreatic cancer (291)
Parkinson's disease (351)
Partnered (33)
Patents (583)
Patient recruitment (644)
Peanut (61)
People (59799)
Pharmaceutical (61)
Pharmacy benefit managers (32)
Phase 1 (22047)
Phase 2 (31124)
Phase 3 (23157)
Pipeline (7937)
Policy (309)
Postmarket research (2567)
Preclinical (9403)
Press Release (65)
Prostate cancer (290)
Psychedelics (52)
Radiopharmaceuticals (317)
Rare diseases (1040)
Real estate (6000)
Recruiting (70)
Regulatory (25328)
Reports (55)
Research institute (2461)
Resumes & cover letters (353)
Rett syndrome (36)
RNA editing (20)
RSV (88)
Schizophrenia (177)
Series A (282)
Series B (208)
Service/supplier (11)
Sickle cell disease (113)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (48)
Startups (3670)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (61)
Vaccines (1082)
Venture capital (104)
Weight loss (441)
Women's health (120)
Worklife (20)
Date
Today (113)
Last 7 days (767)
Last 30 days (2866)
Last 365 days (30321)
2026 (10660)
2025 (30294)
2024 (35367)
2023 (40234)
2022 (51350)
2021 (55888)
2020 (54261)
2019 (46723)
2018 (35174)
2017 (32323)
2016 (31739)
2015 (37795)
2014 (31506)
2013 (26578)
2012 (28772)
2011 (29413)
2010 (27526)
Location
Africa (751)
Alabama (91)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (40027)
Australia (6538)
California (12862)
Canada (3675)
China (1302)
Colorado (548)
Connecticut (561)
Delaware (390)
Europe (86388)
Florida (1924)
Georgia (411)
Hawaii (3)
Idaho (62)
Illinois (1028)
India (88)
Indiana (585)
Iowa (24)
Japan (516)
Kansas (131)
Kentucky (51)
Louisiana (39)
Maine (75)
Maryland (1554)
Massachusetts (9194)
Michigan (354)
Minnesota (697)
Mississippi (6)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (139)
New Hampshire (85)
New Jersey (3395)
New Mexico (28)
New York (3375)
North Carolina (1633)
North Dakota (10)
Northern California (6405)
Ohio (382)
Oklahoma (23)
Oregon (41)
Pennsylvania (2585)
Puerto Rico (28)
Rhode Island (50)
South America (1117)
South Carolina (85)
South Dakota (2)
Southern California (5067)
Tennessee (208)
Texas (2037)
United States (45473)
Utah (383)
Vermont (1)
Virginia (308)
Washington D.C. (80)
Washington State (1031)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
733,037 Results for "radiant genomics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Radiant Biotherapeutics to Present New Data from Lead Oncology Program at SITC 2025 Annual Meeting
November 5, 2025
·
2 min read
Press Releases
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency
April 16, 2026
·
5 min read
Press Releases
Allosteric Bioscience, Inc. Targets Optimizing Aging and Longevity: Quantum Computing, Advanced AI, Genomics
March 5, 2026
·
1 min read
Press Releases
Ecotone AI Breaks the Genomics Cost Barrier, Cutting Genome Processing from $100 to Under $1
New GPU-powered system reduces whole-genome processing time from hours to minutes, unlocking population-scale genetic discovery and accelerating rare disease drug development
February 25, 2026
·
1 min read
Press Releases
Radiant Biotherapeutics to Present Next-Generation Multabody™ Approach for Cancer Immunotherapy at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
October 5, 2025
·
2 min read
Press Releases
Radiant Biotherapeutics Appoints Deborah Geraghty, Ph.D., as President and Chief Executive Officer
July 10, 2025
·
5 min read
Press Releases
Inocras and Broad Institute Researchers Present New TCGA Whole-Genome Cancer Insights, Accelerating Discovery in Cancer Genomics
April 20, 2026
·
5 min read
Press Releases
Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline
August 26, 2025
·
8 min read
Press Releases
KROMATID to Present Breakthrough Genomic Integrity Benchmarking at ASGCT 2026, Powering the World’s First Genomic Intelligence Platform
April 30, 2026
·
2 min read
Press Releases
Praxis Precision Medicines Announces Positive, Best-in-Disease Topline Results in Patients with Focal Onset Seizures from the RADIANT Study of Vormatrigine
August 5, 2025
·
6 min read
1 of 73,304
Next
